Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response

Aya Kuwabara; Anna Babb; Amr Ibrahim; Dragana Milojkovic; Jane Apperley; Marco Bua; Alistair Reid; Letizia Foroni; Katayoun Rezvani; John Goldman; David Marin

doi:10.1182/blood-2010-04-280206

Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response

Aya Kuwabara, Anna Babb, Amr Ibrahim, Dragana Milojkovic, Jane Apperley, Marco Bua, Alistair Reid, Letizia Foroni, Katayoun Rezvani, John Goldman, David Marin

Stem Cell Transplantation

Research output: Contribution to journal › Letter › peer-review

33 Scopus citations

Original language	English (US)
Pages (from-to)	1014-1016
Number of pages	3
Journal	Blood
Volume	116
Issue number	6
DOIs	https://doi.org/10.1182/blood-2010-04-280206
State	Published - Aug 12 2010

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2010-04-280206

Cite this

Kuwabara, A., Babb, A., Ibrahim, A., Milojkovic, D., Apperley, J., Bua, M., Reid, A., Foroni, L., Rezvani, K., Goldman, J., & Marin, D. (2010). Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response. Blood, 116(6), 1014-1016. https://doi.org/10.1182/blood-2010-04-280206

Kuwabara, A, Babb, A, Ibrahim, A, Milojkovic, D, Apperley, J, Bua, M, Reid, A, Foroni, L, Rezvani, K, Goldman, J & Marin, D 2010, 'Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response', Blood, vol. 116, no. 6, pp. 1014-1016. https://doi.org/10.1182/blood-2010-04-280206

@article{f0287c8781d94171bdfef1e1e3cb0252,

title = "Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response",

author = "Aya Kuwabara and Anna Babb and Amr Ibrahim and Dragana Milojkovic and Jane Apperley and Marco Bua and Alistair Reid and Letizia Foroni and Katayoun Rezvani and John Goldman and David Marin",

year = "2010",

month = aug,

day = "12",

doi = "10.1182/blood-2010-04-280206",

language = "English (US)",

volume = "116",

pages = "1014--1016",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "6",

}

TY - JOUR

T1 - Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response

AU - Kuwabara, Aya

AU - Babb, Anna

AU - Ibrahim, Amr

AU - Milojkovic, Dragana

AU - Apperley, Jane

AU - Bua, Marco

AU - Reid, Alistair

AU - Foroni, Letizia

AU - Rezvani, Katayoun

AU - Goldman, John

AU - Marin, David

PY - 2010/8/12

Y1 - 2010/8/12

UR - http://www.scopus.com/inward/record.url?scp=77956507935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956507935&partnerID=8YFLogxK

U2 - 10.1182/blood-2010-04-280206

DO - 10.1182/blood-2010-04-280206

M3 - Letter

C2 - 20705771

AN - SCOPUS:77956507935

SN - 0006-4971

VL - 116

SP - 1014

EP - 1016

JO - Blood

JF - Blood

IS - 6

ER -

Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this